Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01525875
Recruitment Status : Completed
First Posted : February 3, 2012
Last Update Posted : January 20, 2016
Information provided by (Responsible Party):
Mark Lebwohl, Icahn School of Medicine at Mount Sinai

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2015
  Actual Study Completion Date : March 2015

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 10, 2017 May 18, 2017
2 January 8, 2018 February 5, 2018
Blum R, Phelps R, Fuchs W, Lebwohl M. Oral Phosphate Binders in the Treatment of Pseudoxanthoma Elasticum. 64th Annual Meeting American Academy of Dermatology March 3-7, 2006, San Francisco, CA. Manuscript in press J Amer Acad Dermatol 2011
Dietary Reference Intakes for Calcium, Magnesium, Vitamin D and Flouride. IOM Institute of Medicine. 1997 Washington, DC: National Academy Press.